HA
APYX icon

Huntleigh Advisors’s Apyx Medical APYX Stock Holding History

Huntleigh Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
263,231
+17,311
+7% +$68.6K 0.17% 131
2026
Q1 		$907K Buy
245,920
+9,522
+4% +$35.6K 0.16% 128
2025
Q4 		$827K Buy
+236,398
New +$824K 0.14% 132

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Huntleigh Advisors's APYX Position: Q2 2026 in Review

Huntleigh Advisors increased its Apyx Medical (APYX) stake by 7% in Q2 2026, buying an estimated $68.6K and bringing the position to 263,231 shares worth $1.18M. The position accounts for 0.17% of the portfolio, ranked #131.

Huntleigh Advisors first reported a position in APYX in Q4 2025 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Huntleigh Advisors held 263,231 shares of Apyx Medical worth $1.18M as of Q2 2026.
  • Huntleigh Advisors bought 17,311 Apyx Medical shares in Q2 2026, an estimated $68.6K.
  • Apyx Medical made up 0.17% of Huntleigh Advisors's portfolio in Q2 2026, its #131 holding.
  • Huntleigh Advisors first reported a position in Apyx Medical in Q4 2025 and has held it in 3 quarters since.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Huntleigh Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.